Author/Authors :
Kontoravdis, Nikolaos Department of Surgery - Aretaieion University Hospital , Vassilikostas, George Department of Surgery - Aretaieion University Hospital , Lagoudianakis, Emmanuel E Department of Surgery - 401 Army General Hospital , Pappas, Apostolos Department of Propaedeutic Surgery - Hippokrateion Hospital - Athens Medical School - University of Athens , Seretis, Charalampos Department of Surgery - 401 Army General Hospital , Panagiotopoulos, Nikolaos Department of Surgery - 401 Army General Hospital , Koronakis, Nikolaos Department of Surgery - 401 Army General Hospital , Chrysikos, John Department of Surgery - 417 Nosileutiko Idrima Metohikou Tameiou Stratou (Military Veterans’ Fund Hospital , Karanikas, George Department of Surgery - 417 Nosileutiko Idrima Metohikou Tameiou Stratou (Military Veterans’ Fund Hospital , Manouras, Ioannis Department of Propaedeutic Surgery - Hippokrateion Hospital - Athens Medical School - University of Athens , Legakis, Ioanis Department of Endocrinology - Henry Dunant Hospital - Athens, Greece , Voros, Dionysios Department of Surgery - Aretaieion University Hospital
Abstract :
Ghrelin, a 28-amino-acid peptide, is the endogenous
ligand for the growth hormone (GH) secretagogue
receptor and its discovery has led to a more thorough
understanding of the close interplay between energy
balance, regulation of appetite, and gastrointestinal
functionality.[1,2] Mainly secreted by gastric cells, ghrelin
has traditionally been associated with the stimulation
of appetite and increase of food intake as well as with
the stimulation of GH secretion and the exhibition of a
prokinetic effect upon the upper gastrointestinal (UGI)
tract.
Keywords :
Is ghrelin a potential candidate? , biomarkers , UGI , TNF-α
